Markets

Imagine being outbid for a single family home by a corporation. That was all too real for the last few years as investor real estate purchases surged, fueling the Pandemic Housing Boom and and pricing many aspiring home buyers out of the market. Last year the average 30-year fixed mortgage …

“‘The risk is that we’re going to hit the brakes very, very hard.’ ” — Larry Summers Almost a full year of monetary-policy tightening by the Federal Reserve appears to be having little impact on price pressures, putting policy makers in danger of needing to do much more, according to …

U.S. stocks fell Friday morning as investors pointed to a continued risk-off tone, with tech stocks underperforming, bond yields higher, and a stronger dollar. The S&P 500 (^GSPC) slumped by 0.6%, while the Dow Jones Industrial Average (^DJI) declined by 0.5%. The technology-heavy Nasdaq Composite (^IXIC) plunged by more than …

Inozyme Pharma Inc (NASDAQ: INZY) announced topline pharmacokinetic (PK), pharmacodynamic (PD), and safety data from the ongoing Phase 1/2 trials of INZ-701 in ENPP1 Deficiency and ABCC6 Deficiency (PXE). Rapid, significant, and sustained increase in plasma pyrophosphate (PPi) was observed, and an encouraging patient-reported outcome data in all dose cohorts in the ENPP1 …

Text size The New York Stock Exchange. Spencer Platt/Getty Images Investors just don’t feel confident about stocks’ rally over the past few months, but the market could still hold up well this spring. The S&P 500 has risen about 15% since early October, when it hit its low point in …